Novo-Nordisk, DK0062498333

Novo-Nordisk stock heads into the open after a 2.53 percent drop

Published on 09/24/2026 at 08:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Novo-Nordisk stock stood at DKK 252.25 after falling 2.53 percent on Nasdaq Copenhagen. The shares were down 7.47 percent over five trading days, while the next quarterly results are scheduled for November 3, 2026.

Flatlay mit Spritze, Teststreifen, Notizbuch und Apfel auf weißem Untergrund
Novo Nordisk A/S (DK0062498333): Flatlay mit Spritze, Blutzucker-Teststreifen, Notizbuch und Apfel auf Weiß, Illustration mit AI erstellt.

Novo-Nordisk stock closed at DKK 252.25 on Nasdaq Copenhagen on September 23, 2026, down 2.53 percent from the prior close. The shares fell more than the OMX Copenhagen 20, which lost 0.95 percent in the same session.

September 23, 2026 in numbers

Novo Nordisk A/S (ISIN DK0062498333) ended the session at DKK 252.25, extending its decline to 7.47 percent over five trading days and 22.44 percent since January 1, 2026. The latest market data also showed a 2.53 percent session loss at the September 23, 2026 close.

As Ad Hoc News reported on September 23, 2026, the company outlined five strategic milestones for 2030. CNBC reported that the strategy included plans for more than five potential blockbuster drugs by 2030.

Today and the next reporting date

The next quarterly results are scheduled for November 3, 2026, according to Ad Hoc News. The calendar also includes United States economic releases on September 24, 2026, including second-quarter current account data and August new home sales, as listed by SVMUU.

Disclaimer...

en | DK0062498333 | NOVO-NORDISK | boerse | 70174969 | bgmi